CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $742,785 | -67.6% | 442,134 | -45.4% | 0.00% | – |
| Q2 2023 | $2,291,546 | -38.7% | 809,734 | +6.4% | 0.00% | – |
| Q1 2023 | $3,735,774 | -48.2% | 760,850 | +13.4% | 0.00% | -100.0% |
| Q4 2022 | $7,205,079 | +1175.2% | 670,864 | +1009.4% | 0.00% | – |
| Q3 2022 | $565,000 | +76.0% | 60,469 | +71.8% | 0.00% | – |
| Q2 2022 | $321,000 | -57.5% | 35,201 | -43.4% | 0.00% | – |
| Q1 2022 | $756,000 | -31.3% | 62,176 | -31.1% | 0.00% | – |
| Q4 2021 | $1,100,000 | -0.4% | 90,289 | +26.3% | 0.00% | – |
| Q3 2021 | $1,104,000 | -60.8% | 71,482 | -63.8% | 0.00% | – |
| Q2 2021 | $2,819,000 | -74.6% | 197,547 | -61.3% | 0.00% | -100.0% |
| Q1 2021 | $11,084,000 | +29.2% | 510,554 | -9.9% | 0.00% | 0.0% |
| Q4 2020 | $8,576,000 | -40.3% | 566,830 | -49.8% | 0.00% | -50.0% |
| Q3 2020 | $14,369,000 | -16.4% | 1,129,197 | +12.3% | 0.00% | -33.3% |
| Q2 2020 | $17,195,000 | +43.9% | 1,005,524 | +11.2% | 0.00% | +50.0% |
| Q1 2020 | $11,946,000 | +75.9% | 904,297 | +114.5% | 0.00% | +100.0% |
| Q4 2019 | $6,792,000 | +106.1% | 421,581 | +133.8% | 0.00% | – |
| Q3 2019 | $3,296,000 | -32.7% | 180,310 | -20.8% | 0.00% | -100.0% |
| Q2 2019 | $4,897,000 | -42.5% | 227,720 | -47.6% | 0.00% | 0.0% |
| Q1 2019 | $8,523,000 | +2096.6% | 434,451 | +1352.6% | 0.00% | – |
| Q4 2018 | $388,000 | -16.6% | 29,908 | +53.9% | 0.00% | – |
| Q3 2018 | $465,000 | -60.5% | 19,430 | -68.4% | 0.00% | – |
| Q2 2018 | $1,177,000 | +296.3% | 61,429 | +156.3% | 0.00% | – |
| Q1 2018 | $297,000 | -4.8% | 23,967 | -6.2% | 0.00% | – |
| Q4 2017 | $312,000 | -13.6% | 25,539 | -3.2% | 0.00% | – |
| Q3 2017 | $361,000 | -1.1% | 26,370 | +11.0% | 0.00% | – |
| Q2 2017 | $365,000 | +22.5% | 23,755 | +46.6% | 0.00% | – |
| Q1 2017 | $298,000 | +79.5% | 16,209 | -9.5% | 0.00% | – |
| Q4 2016 | $166,000 | +29.7% | 17,913 | +16.9% | 0.00% | – |
| Q3 2016 | $128,000 | +96.9% | 15,329 | +13.9% | 0.00% | – |
| Q2 2016 | $65,000 | +6.6% | 13,463 | +38.1% | 0.00% | – |
| Q1 2016 | $61,000 | -77.9% | 9,748 | -40.5% | 0.00% | – |
| Q4 2015 | $276,000 | +104.4% | 16,394 | +73.8% | 0.00% | – |
| Q3 2015 | $135,000 | +17.4% | 9,432 | -0.8% | 0.00% | – |
| Q2 2015 | $115,000 | +21.1% | 9,504 | +0.7% | 0.00% | – |
| Q1 2015 | $95,000 | -12.8% | 9,442 | -13.6% | 0.00% | – |
| Q4 2014 | $109,000 | +11.2% | 10,927 | -6.8% | 0.00% | – |
| Q3 2014 | $98,000 | +75.0% | 11,727 | +257.4% | 0.00% | – |
| Q2 2014 | $56,000 | – | 3,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |